BetterLife Pharma (FRA:NPAU) Cyclically Adjusted Book per Share: €0.04 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NPAU BetterLife Pharma Inc FRA:NPAU
36 GF Score
Price €0.13
! 2 Warning Signs
View Full Analysis

What is BetterLife Pharma Cyclically Adjusted Book per Share?

BetterLife Pharma FRA:NPAU -0.74% 36 Cyclically Adjusted Book per Share is €0.04 as of Apr. 2026. GuruFocus rates FRA:NPAU with a GF Score™ of 36/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BetterLife Pharma's adjusted book value per share for the three months ended in Apr. 2026 was €-0.037. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.04 for the trailing ten years ended in Apr. 2026.

During the past 12 months, BetterLife Pharma's average Cyclically Adjusted Book Growth Rate was -14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BetterLife Pharma was 42.80% per year. The lowest was 29.40% per year. And the median was 36.10% per year.

As of today (2026-07-21), BetterLife Pharma's current stock price is €0.134. BetterLife Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Apr. 2026 was €0.04. BetterLife Pharma's Cyclically Adjusted PB Ratio of today is 3.35.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BetterLife Pharma was 3.46. The lowest was 0.00. And the median was 0.00.


BetterLife Pharma  (FRA:NPAU) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BetterLife Pharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.134/0.04
=3.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BetterLife Pharma was 3.46. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BetterLife Pharma Cyclically Adjusted Book per Share Related Terms


BetterLife Pharma Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma Cyclically Adjusted Book per Share Chart

BetterLife Pharma Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 -0.10 0.01 0.04 0.03

BetterLife Pharma Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.03 0.03 0.04

FRA:NPAU vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, BetterLife Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Cyclically Adjusted PB Ratio falls into.


FRA:NPAU
36GF Score
BetterLife Pharma Inc FRA:NPAU
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BetterLife Pharma's adjusted Book Value per Share data for the three months ended in Apr. 2026 was:

Adj_Book= Book Value per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=-0.037/132.7364*132.7364
=-0.037

Current CPI (Apr. 2026) = 132.7364.

BetterLife Pharma Quarterly Data

Book Value per Share CPI Adj_Book
201607 -0.084 101.844 -0.109
201610 -0.141 102.002 -0.183
201701 -0.182 102.318 -0.236
201704 -0.217 103.029 -0.280
201707 -0.144 103.029 -0.186
201710 0.020 103.424 0.026
201801 -0.004 104.056 -0.005
201804 0.429 105.320 0.541
201807 0.317 106.110 0.397
201810 0.314 105.952 0.393
201901 0.238 105.557 0.299
201904 0.212 107.453 0.262
201907 0.659 108.243 0.808
201910 0.583 107.927 0.717
202001 0.106 108.085 0.130
202004 0.113 107.216 0.140
202007 0.083 108.401 0.102
202010 0.041 108.638 0.050
202101 -0.058 109.192 -0.071
202104 -0.043 110.851 -0.051
202107 0.010 112.431 0.012
202110 -0.006 113.695 -0.007
202201 -0.032 114.801 -0.037
202204 -0.055 118.357 -0.062
202207 -0.065 120.964 -0.071
202210 -0.085 121.517 -0.093
202301 -0.082 121.596 -0.090
202304 -0.056 123.571 -0.060
202307 -0.059 124.914 -0.063
202310 -0.056 125.310 -0.059
202401 -0.064 125.072 -0.068
202404 -0.063 126.890 -0.066
202407 -0.056 128.075 -0.058
202410 -0.052 127.838 -0.054
202501 -0.055 127.443 -0.057
202504 -0.041 129.102 -0.042
202507 -0.038 130.290 -0.039
202510 -0.038 130.603 -0.039
202601 -0.040 130.366 -0.041
202604 -0.037 132.736 -0.037

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.04 mean?
BetterLife Pharma (FRA:NPAU) has a Cyclically Adjusted Book per Share of €0.04 as of Apr. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BetterLife Pharma and its competitors.
Is BetterLife Pharma's Cyclically Adjusted Book per Share too high?
BetterLife Pharma's current Cyclically Adjusted Book per Share is €0.04. Overall, BetterLife Pharma has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's Cyclically Adjusted Book per Share compare to VRTX and REGN?
BetterLife Pharma's Cyclically Adjusted Book per Share of €0.04 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BetterLife Pharma and its competitors. BetterLife Pharma's current Cyclically Adjusted Book per Share is €0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (FRA:NPAU) has a current Cyclically Adjusted Book per Share of €0.04. The current Cyclically Adjusted Book per Share is €0.04. BetterLife Pharma's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For BetterLife Pharma (FRA:NPAU), the current Cyclically Adjusted Book per Share is €0.04 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
36GF Score

Get the complete analysis for FRA:NPAU

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.13
Price